Haploinsufficiency of the ESCRT Component HD-PTP Predisposes to Cancer

Cell Reports

Volumn 15, Issue 9, 2016, Pages 1893-1900

  Manteghi, Sanaz ^a,b   Gingras, Marie Claude ^a,b   Kharitidi, Dmitri ^a,b   Galarneau, Luc ^a,b   Marques, Maud ^d   Yan, Ming ^a,b   Cencic, Regina ^a,b   Robert, Francis ^a,b   Paquet, Marilène ^c   Witcher, Michael ^d   Pelletier, Jerry ^a,b   Pause, Arnim ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; ESCRT PROTEIN; FOCAL ADHESION KINASE; MYC PROTEIN; INTEGRIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE; PTPN23 PROTEIN, HUMAN; PTPN23 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LYMPHOMA; CANCER INCIDENCE; CANCER SURVIVAL; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; GENE DELETION; GENE EXPRESSION REGULATION; GENE INACTIVATION; HAPLOINSUFFICIENCY; HEMIZYGOSITY; HEMIZYGOSITY LOSS; IN VIVO STUDY; LOSS OF FUNCTION MUTATION; LUNG ADENOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PTPN23 GENE; TUMOR SUPPRESSOR GENE; ANIMAL; C57BL MOUSE; CELL MOTION; CELL SURVIVAL; GENETIC PREDISPOSITION; GENETICS; HEMIZYGOTE; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; TUMOR INVASION;

ANIMALS; CARCINOGENESIS; CELL MOVEMENT; CELL SURVIVAL; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; GENETIC PREDISPOSITION TO DISEASE; HAPLOINSUFFICIENCY; HEMIZYGOTE; HUMANS; INTEGRINS; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; NEOPLASMS; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 84971267990     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.04.076     Document Type: Article

References (33)

1. Adams J.M., Harris A.W., Pinkert C.A., Corcoran L.M., Alexander W.S., Cory S., Palmiter R.D., Brinster R.L. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 1985, 318:533-538.
2. Alanko J., Mai A., Jacquemet G., Schauer K., Kaukonen R., Saari M., Goud B., Ivaska J. Integrin endosomal signalling suppresses anoikis. Nat. Cell Biol. 2015, 17:1412-1421.
3. Angeloni D. Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease. Brief. Funct. Genomics Proteomics 2007, 6:19-39.
4. Bosch R., Dieguez-Gonzalez R., Céspedes M.V., Parreño M., Pavón M.Á., Grañena A., Sierra J., Mangues R., Casanova I. A novel inhibitor of focal adhesion signaling induces caspase-independent cell death in diffuse large B-cell lymphoma. Blood 2011, 118:4411-4420.
5. Castiglioni S., Maier J.A., Mariotti M. The tyrosine phosphatase HD-PTP: A novel player in endothelial migration. Biochem. Biophys. Res. Commun. 2007, 364:534-539.
6. Caswell P.T., Chan M., Lindsay A.J., McCaffrey M.W., Boettiger D., Norman J.C. Rab-coupling protein coordinates recycling of α5β1 integrin and EGFR1 to promote cell migration in 3D microenvironments. J. Cell Biol. 2008, 183:143-155.
7. Cerami E., Gao J., Dogrusoz U., Gross B.E., Sumer S.O., Aksoy B.A., Jacobsen A., Byrne C.J., Heuer M.L., Larsson E., et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012, 2:401-404.
8. Delamarre E., Taboubi S., Mathieu S., Bérenguer C., Rigot V., Lissitzky J.-C., Figarella-Branger D., Ouafik L., Luis J. Expression of integrin α6β1 enhances tumorigenesis in glioma cells. Am. J. Pathol. 2009, 175:844-855.
9. Desgrosellier J.S., Cheresh D.A. Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 2010, 10:9-22.
10. Dozynkiewicz M.A., Jamieson N.B., Macpherson I., Grindlay J., van den Berghe P.V., von Thun A., Morton J.P., Gourley C., Timpson P., Nixon C., et al. Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes/lysosomes and drive cancer progression. Dev. Cell 2012, 22:131-145.
11. Eischen C.M., Weber J.D., Roussel M.F., Sherr C.J., Cleveland J.L. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev. 1999, 13:2658-2669.
12. Gao J., Aksoy B.A., Dogrusoz U., Dresdner G., Gross B., Sumer S.O., Sun Y., Jacobsen A., Sinha R., Larsson E., et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 2013, 6:pl1.
13. Gingras M.-C., Kharitidi D., Chénard V., Uetani N., Bouchard M., Tremblay M.L., Pause A. Expression analysis and essential role of the putative tyrosine phosphatase His-domain-containing protein tyrosine phosphatase (HD-PTP). Int. J. Dev. Biol. 2009, 53:1069-1074.
14. Gingras M.-C., Zhang Y.L., Kharitidi D., Barr A.J., Knapp S., Tremblay M.L., Pause A. HD-PTP is a catalytically inactive tyrosine phosphatase due to a conserved divergence in its phosphatase domain. PLoS ONE 2009, 4:e5105.
15. Györffy B., Lanczky A., Eklund A.C., Denkert C., Budczies J., Li Q., Szallasi Z. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res. Treat. 2010, 123:725-731.
16. Gyorffy B., Surowiak P., Budczies J., Lánczky A. Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS ONE 2013, 8:e82241.
17. Hung J., Kishimoto Y., Sugio K., Virmani A., McIntire D.D., Minna J.D., Gazdar A.F. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 1995, 273:558-563.
18. Ji L., Minna J.D., Roth J.A. 3p21.3 tumor suppressor cluster: prospects for translational applications. Future Oncol. 2005, 1:79-92.
19. Kamijo T., Zindy F., Roussel M.F., Quelle D.E., Downing J.R., Ashmun R.A., Grosveld G., Sherr C.J. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 1997, 91:649-659.
20. Kharitidi D., Apaja P.M., Manteghi S., Suzuki K., Malitskaya E., Roldan A., Gingras M.-C., Takagi J., Lukacs G.L., Pause A. Interplay of endosomal pH and ligand occupancy in integrin α5β1 ubiquitination, endocytic sorting, and cell migration. Cell Rep. 2015, 13:599-609.
21. Lerman M.I., Minna J.D. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res. 2000, 60:6116-6133.
22. Lin G., Aranda V., Muthuswamy S.K., Tonks N.K. Identification of PTPN23 as a novel regulator of cell invasion in mammary epithelial cells from a loss-of-function screen of the 'PTP-ome'. Genes Dev. 2011, 25:1412-1425.
23. Mariotti M., Castiglioni S., Garcia-Manteiga J.M., Beguinot L., Maier J.A. HD-PTP inhibits endothelial migration through its interaction with Src. Int. J. Biochem. Cell Biol. 2009, 41:687-693.
24. Mattissek C., Teis D. The role of the endosomal sorting complexes required for transport (ESCRT) in tumorigenesis. Mol. Membr. Biol. 2014, 31:111-119.
25. Mellman I., Yarden Y. Endocytosis and cancer. Cold Spring Harb. Perspect. Biol. 2013, 5:a016949.
26. Raiborg C., Stenmark H. The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 2009, 458:445-452.
27. Ruas M., Peters G. The p16 INK4a/CDKN2A tumor suppressor and its relatives. Biochim. Biophys. 1998, 1378:F115-F177.
28. Schmitz R., Young R.M., Ceribelli M., Jhavar S., Xiao W., Zhang M., Wright G., Shaffer A.L., Hodson D.J., Buras E., et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 2012, 490:116-120.
29. Stroeken P.J., van Rijthoven E.A., van der Valk M.A., Roos E. Targeted disruption of the β1 integrin gene in a lymphoma cell line greatly reduces metastatic capacity. Cancer Res. 1998, 58:1569-1577.
30. Stroeken P.J., van Rijthoven E.A., Boer E., Geerts D., Roos E. Cytoplasmic domain mutants of beta1 integrin, expressed in beta 1-knockout lymphoma cells, have distinct effects on adhesion, invasion and metastasis. Oncogene 2000, 19:1232-1238.
31. Tanaka K., Kondo K., Kitajima K., Muraoka M., Nozawa A., Hara T. Tumor-suppressive function of protein-tyrosine phosphatase non-receptor type 23 in testicular germ cell tumors is lost upon overexpression of miR142-3p microRNA. J. Biol. Chem. 2013, 288:23990-23999.
32. Wistuba I.I., Behrens C., Milchgrub S., Bryant D., Hung J., Minna J.D., Gazdar A.F. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 1999, 18:643-650.
33. Wittinger M., Vanhara P., El-Gazzar A., Savarese-Brenner B., Pils D., Anees M., Grunt T.W., Sibilia M., Holcmann M., Horvat R., et al. hVps37A Status affects prognosis and cetuximab sensitivity in ovarian cancer. Clin. Cancer Res. 2011, 17:7816-7827.